Skip to main content
    P

    Pasithea Therapeutics Corp (KTTA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.50
    -0.02 (-4.21%)

    Market Cap: $17.44M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Pasithea Therapeutics Corp (KTTA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Pasithea Therapeutics are Pelthos Therapeutics (PTHS), Plus Therapeutics (PSTV) and Phio Pharmaceuticals (PHIO). By market cap, Pasithea Therapeutics ranks 7th of the 13 companies on this page; Briacell Therapeutics (BCTX) is the largest at $29.60M.

    Peer Comparison

    KTTA's revenue growth of 1498.0% is above the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Pasithea Therapeutics (KTTA)$17.44MN/AN/A0.0%N/A1498.0%0.00%
    Pelthos Therapeutics Inc. (PTHS)$29.24MN/A0.5x-199.5%-95.4%0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Phio Pharmaceuticals Corp (PHIO)$9.21MN/AN/A0.0%N/A0.0%0.00%
    Marker Therapeutics Inc (MRKR)$14.51MN/A14.5x-245.5%N/A-51.0%0.00%
    Passage Bio Inc (PASG)$13.68MN/AN/A0.0%N/A0.0%0.00%
    Transcode Therapeutics Inc (RNAZ)$22.35MN/AN/A0.0%-412.7%0.0%0.00%
    Estrella Immunopharma Inc. (ESLA)$22.36MN/AN/A0.0%N/A0.0%0.00%
    Psyence Biomedical Ltd. Common Shares (PBM)$12.00MN/AN/A0.0%N/A0.0%0.00%
    Immutep Ltd ADR (IMMP)$25.64MN/A2.2x0.0%N/A633.0%0.00%
    Briacell Therapeutics Corp (BCTX)$29.60MN/AN/A0.0%N/A0.0%0.00%
    Collplant Biotechnologies Ltd (CLGN)$14.27MN/A21.0x0.0%N/A-39.7%0.00%
    Citius Pharmaceuticals Inc (CTXR)$14.69MN/A1.9x0.0%-84.3%0.0%0.00%
    Peer median$18.52MN/A2.1x0.0%-254.1%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Pasithea Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Pelthos Therapeutics Inc. (PTHS)
    Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
    PTHS competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Phio Pharmaceuticals Corp (PHIO)
    Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
    PHIO competitors
    Marker Therapeutics Inc (MRKR)
    Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based...
    MRKR competitors
    Passage Bio Inc (PASG)
    Passage Bio, Inc., a genetic drug company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases.
    PASG competitors
    Transcode Therapeutics Inc (RNAZ)
    TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic...
    RNAZ competitors
    Estrella Immunopharma Inc. (ESLA)
    Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
    ESLA competitors
    Psyence Biomedical Ltd. Common Shares (PBM)
    Psyence Biomedical Ltd. (PBM) is an innovative biotechnology company focused on harnessing the therapeutic potential of psychedelic compounds to address mental...
    Immutep Ltd ADR (IMMP)
    Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates.
    Briacell Therapeutics Corp (BCTX)
    BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
    BCTX competitors
    Collplant Biotechnologies Ltd (CLGN)
    CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs...
    CLGN competitors
    Citius Pharmaceuticals Inc (CTXR)
    Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products.
    CTXR competitors

    Frequently Asked Questions About KTTA

    Who are Pasithea Therapeutics' main competitors?

    The companies most similar to Pasithea Therapeutics include Pelthos Therapeutics (PTHS), Plus Therapeutics (PSTV), Phio Pharmaceuticals (PHIO), Marker Therapeutics (MRKR) and Passage Bio (PASG), listed from the closest match.

    Who is Pasithea Therapeutics' biggest competitor?

    Briacell Therapeutics (BCTX) is the largest of the similar companies at $29.60M; Pelthos Therapeutics (PTHS) is the closest match by business profile, size, sector and industry.

    How does KTTA stock compare with its competitors?

    KTTA's net margin is 0.0% against a peer median of 0.0%.

    Which of Pasithea Therapeutics' competitors pays a higher dividend?

    Pasithea Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Pasithea Therapeutics bigger than its competitors?

    No. Pasithea Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Briacell Therapeutics (BCTX) at $29.60M.